David B. Schwartz shares insight with The Wall Street Journal about Private Equity

Partner David B. Schwartz recently spoke with The Wall Street Journal about private equity. The Wall Street Journal reported that private equity has had a year of milder antitrust scrutiny under the Trump administration, and a recent court ruling may lighten the load even further. 

David said that over the past year, he has “seen an abandonment of the theory the Biden administration had about why private equity deserves special focus.”

David specializes in “network” or “platform” antitrust matters, ranging from online retail platforms, sports technologies, or multifaceted healthcare networks. He has significant experience in the healthcare sector, having worked extensively on enforcement issues related to pharmaceutical pricing, private equity provider acquisitions, and Medicare Modernization Act patent settlements.